Found: 96
Select item for more details and to access through your institution.
Pharmacogenetics-based therapeutic recommendations--ready for clinical practice?
- Published in:
- 2005
- By:
- Publication type:
- review
Physiologically‐based pharmacokinetic modeling of dextromethorphan to investigate interindividual variability within CYP2D6 activity score groups.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 4, p. 494, doi. 10.1002/psp4.12776
- By:
- Publication type:
- Article
Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6281, doi. 10.3390/cancers13246281
- By:
- Publication type:
- Article
A Population Pharmacokinetic Model of (R)‐ and (S‐) Oxybutynin and Its Active Metabolites After Oral and Intravesical Administration to Healthy Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 7, p. 961, doi. 10.1002/jcph.1809
- By:
- Publication type:
- Article
A Novel Study Design Using Continuous Intravenous and Intraduodenal Infusions of Midazolam and Voriconazole for Mechanistic Quantitative Assessment of Hepatic and Intestinal CYP3A Inhibition.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 9, p. 1237, doi. 10.1002/jcph.1619
- By:
- Publication type:
- Article
Population Pharmacokinetic Analysis of Circadian Rhythms in Hepatic CYP3A Activity Using Midazolam.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 10, p. 1162, doi. 10.1002/jcph.318
- By:
- Publication type:
- Article
Pharmacogenetic-Based Clinical Scores: A Useful, Simple Tool to Predict Tamoxifen-Based CYP2D6 Phenotype?
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 4, p. 370, doi. 10.1177/0091270009353605
- By:
- Publication type:
- Article
Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1271, doi. 10.1007/s00228-024-03697-3
- By:
- Publication type:
- Article
Understanding adefovir pharmacokinetics as a component of a transporter phenotyping cocktail.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 7, p. 1069, doi. 10.1007/s00228-024-03673-x
- By:
- Publication type:
- Article
Improved correction formulas to estimate iohexol clearance from simple models.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1215, doi. 10.1007/s00228-023-03535-y
- By:
- Publication type:
- Article
A population pharmacokinetic model for creatinine with and without ingestion of a cooked meat meal.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
The parent drugs chloroquine and hydroxychloroquine do not inhibit human CYP3A activity in vitro.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Adverse events during placebo vs. no drug administration-results of a randomised interventional trial in 160 volunteers.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Channeling the flood of meta-analyses.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Natriuretic peptides in therapy for decompensated heart failure.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 3, p. 223, doi. 10.1007/s00228-011-1117-1
- By:
- Publication type:
- Article
Clinical impact of fluvoxamine-mediated long QTU syndrome.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH)
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH).
- Published in:
- European Journal of Clinical Pharmacology, 2011, v. 67, n. 4, p. 333, doi. 10.1007/s00228-011-1006-7
- By:
- Publication type:
- Article
A Modeling and Simulation Framework for Adverse Events in Erlotinib-Treated Non-Small-Cell Lung Cancer Patients.
- Published in:
- AAPS Journal, 2015, v. 17, n. 6, p. 1483, doi. 10.1208/s12248-015-9815-8
- By:
- Publication type:
- Article
Modeling NSCLC Progression: Recent Advances and Opportunities Available.
- Published in:
- AAPS Journal, 2013, v. 15, n. 2, p. 542, doi. 10.1208/s12248-013-9461-y
- By:
- Publication type:
- Article
Population Pharmacokinetics as a Tool to Reevaluate the Complex Disposition of Ethanol in the Fed and Fasted States.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 6, p. 681, doi. 10.1002/jcph.2205
- By:
- Publication type:
- Article
Academia and industry agreement on a feasibility tool for first‐time‐in‐human clinical trial units.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2421, doi. 10.1111/cts.13655
- By:
- Publication type:
- Article
Reactivities of Organic Phase Biosensors 3: Electrochemical Study of Cytochrome P450<sub>cam</sub> Immobilized in a Methyltriethoxysilane Sol-Gel.
- Published in:
- Electroanalysis, 2000, v. 12, n. 12, p. 980, doi. 10.1002/1521-4109(200008)12:12<980::AID-ELAN980>3.0.CO;2-F
- By:
- Publication type:
- Article
Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent haemodialysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Ciprofloxacin in critically ill subjects: considering hepatic function, age and sex to choose the optimal dose.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Using a three-compartment model improves the estimation of iohexol clearance to assess glomerular filtration rate.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-35989-x
- By:
- Publication type:
- Article
Quantification of mephenytoin and its metabolites 4′-hydroxymephenytoin and nirvanol in human urine using a simple sample processing method.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2004, v. 18, n. 15, p. 1675, doi. 10.1002/rcm.1539
- By:
- Publication type:
- Article
Quantification of cyclophosphamide and its metabolites in urine using liquid chromatography/tandem mass spectrometry.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2004, v. 18, n. 13, p. 1472, doi. 10.1002/rcm.1508
- By:
- Publication type:
- Article
Torsades de pointes tachycardia induced by common cold compound medication containing chlorpheniramine.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Phenotyping of N-acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected?
- Published in:
- European Journal of Clinical Pharmacology, 2009, v. 65, n. 4, p. 411, doi. 10.1007/s00228-008-0597-0
- By:
- Publication type:
- Article
Influence of posture on pharmacokinetics.
- Published in:
- European Journal of Clinical Pharmacology, 2009, v. 65, n. 2, p. 109, doi. 10.1007/s00228-008-0579-2
- By:
- Publication type:
- Article
Identification of a novel non-functional CYP2D6 allele, CYP2D6*69, in a Caucasian poor metabolizer individual.
- Published in:
- European Journal of Clinical Pharmacology, 2009, v. 65, n. 1, p. 97, doi. 10.1007/s00228-008-0559-6
- By:
- Publication type:
- Article
Relative potency of proton-pump inhibitors—comparison of effects on intragastric pH.
- Published in:
- European Journal of Clinical Pharmacology, 2009, v. 65, n. 1, p. 19, doi. 10.1007/s00228-008-0576-5
- By:
- Publication type:
- Article
Mesalazine pharmacokinetics and NAT2 phenotype.
- Published in:
- European Journal of Clinical Pharmacology, 2009, v. 65, n. 1, p. 47, doi. 10.1007/s00228-008-0550-2
- By:
- Publication type:
- Article
Professor Dr. Nina Bakracheva.
- Published in:
- 2008
- By:
- Publication type:
- Obituary
Modelling ocular pharmacokinetics of fluorescein administered as lyophilisate or conventional eye drops.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 5, p. 521, doi. 10.1007/s00228-007-0457-3
- By:
- Publication type:
- Article
Assessment of urinary mephenytoin metrics to phenotype for CYP2C19 and CYP2B6 activity.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 4, p. 387, doi. 10.1007/s00228-007-0416-z
- By:
- Publication type:
- Article
Improvement in the handling of drug–drug interactions.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
What is the true risk of a pharmacokinetic drug–drug interaction?
- Published in:
- 2007
- By:
- Publication type:
- Editorial
Cytochrome P<sub>450</sub> 2C9 phenotyping using low-dose tolbutamide.
- Published in:
- European Journal of Clinical Pharmacology, 2004, v. 60, n. 3, p. 165, doi. 10.1007/s00228-004-0754-z
- By:
- Publication type:
- Article
Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposure.
- Published in:
- European Journal of Clinical Pharmacology, 2004, v. 60, n. 1, p. 17, doi. 10.1007/s00228-003-0718-8
- By:
- Publication type:
- Article
Professor Norbert H. Rietbrock.
- Published in:
- 2003
- By:
- Publication type:
- Obituary
Effects of grapefruit juice and smoking on verapamil concentrations in steady state.
- Published in:
- European Journal of Clinical Pharmacology, 2002, v. 58, n. 1, p. 45, doi. 10.1007/s00228-002-0436-7
- By:
- Publication type:
- Article
The Role of Human CYP2C8 and CYP2C9 Variants in Pioglitazone Metabolism In Vitro.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2009, v. 105, n. 6, p. 374, doi. 10.1111/j.1742-7843.2009.00457.x
- By:
- Publication type:
- Article
Assessment of CYP1A2 Activity in Clinical Practice: Why, How, and When?
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2005, v. 97, n. 3, p. 125, doi. 10.1111/j.1742-7843.2005.pto_973160.x
- By:
- Publication type:
- Article
Population pharmacokinetics of meropenem in patients undergoing automated peritoneal dialysis.
- Published in:
- Peritoneal Dialysis International, 2023, v. 43, n. 5, p. 402, doi. 10.1177/08968608231167237
- By:
- Publication type:
- Article
Bioequivalence between novel ready-to-use liquid formulations of the recombinant human GH Omnitrope and the original lyophilized formulations for reconstitution of Omnitrope and Genotropin.
- Published in:
- European Journal of Endocrinology, 2010, v. 162, n. 6, p. 1051, doi. 10.1530/EJE-09-1101
- By:
- Publication type:
- Article
Optimization of linezolid therapy in the critically ill: the effect of adjusted infusion regimens.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Physiologically Based Pharmacokinetic Modeling of Bergamottin and 6,7‐Dihydroxybergamottin to Describe CYP3A4 Mediated Grapefruit‐Drug Interactions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 470, doi. 10.1002/cpt.2968
- By:
- Publication type:
- Article
A Model‐Based Approach to Assess Unstable Creatinine Clearance in Critically Ill Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1240, doi. 10.1002/cpt.2341
- By:
- Publication type:
- Article